ArticleThe American journal of gastroenterology2014

Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.

Xiaobin Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.